BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4296 related articles for article (PubMed ID: 21901722)

  • 1. The effect of financial incentives on the quality of health care provided by primary care physicians.
    Scott A; Sivey P; Ait Ouakrim D; Willenberg L; Naccarella L; Furler J; Young D
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008451. PubMed ID: 21901722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Payment methods for healthcare providers working in outpatient healthcare settings.
    Jia L; Meng Q; Scott A; Yuan B; Zhang L
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011865. PubMed ID: 33469932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paying for performance to improve the delivery of health interventions in low- and middle-income countries.
    Diaconu K; Falconer J; Verbel A; Fretheim A; Witter S
    Cochrane Database Syst Rev; 2021 May; 5(5):CD007899. PubMed ID: 33951190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of different methods of remuneration on the behaviour of primary care dentists.
    Brocklehurst P; Price J; Glenny AM; Tickle M; Birch S; Mertz E; Grytten J
    Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD009853. PubMed ID: 24194456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pay for performance for hospitals.
    Mathes T; Pieper D; Morche J; Polus S; Jaschinski T; Eikermann M
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011156. PubMed ID: 31276606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paying for performance to improve the delivery of health interventions in low- and middle-income countries .
    Witter S; Fretheim A; Kessy FL; Lindahl AK
    Cochrane Database Syst Rev; 2012 Feb; (2):CD007899. PubMed ID: 22336833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Payment methods for outpatient care facilities.
    Yuan B; He L; Meng Q; Jia L
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011153. PubMed ID: 28253540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes.
    Flodgren G; Eccles MP; Shepperd S; Scott A; Parmelli E; Beyer FR
    Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD009255. PubMed ID: 21735443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical policies: effects of financial incentives for prescribers.
    Rashidian A; Omidvari AH; Vali Y; Sturm H; Oxman AD
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD006731. PubMed ID: 26239041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical policies: effects of cap and co-payment on rational drug use.
    Austvoll-Dahlgren A; Aaserud M; Vist G; Ramsay C; Oxman AD; Sturm H; Kösters JP; Vernby A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD007017. PubMed ID: 18254125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incentives for preventing smoking in children and adolescents.
    Hefler M; Liberato SC; Thomas DP
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD008645. PubMed ID: 28585288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target payments in primary care: effects on professional practice and health care outcomes.
    Giuffrida A; Gosden T; Forland F; Kristiansen IS; Sergison M; Leese B; Pedersen L; Sutton M
    Cochrane Database Syst Rev; 2000; 1999(3):CD000531. PubMed ID: 10908475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incentives for smoking cessation.
    Cahill K; Hartmann-Boyce J; Perera R
    Cochrane Database Syst Rev; 2015 May; (5):CD004307. PubMed ID: 25983287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial arrangements for health systems in low-income countries: an overview of systematic reviews.
    Wiysonge CS; Paulsen E; Lewin S; Ciapponi A; Herrera CA; Opiyo N; Pantoja T; Rada G; Oxman AD
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011084. PubMed ID: 28891235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can preventive care activities in general practice be sustained when financial incentives and external audit plus feedback are removed? ACCEPt-able: a cluster randomised controlled trial protocol.
    Hocking JS; Temple-Smith M; van Driel M; Law M; Guy R; Bulfone L; Wood A; Low N; Donovan B; Fairley CK; Kaldor J; Gunn J
    Implement Sci; 2016 Sep; 11(1):122. PubMed ID: 27624835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.
    Luiza VL; Chaves LA; Silva RM; Emmerick IC; Chaves GC; Fonseca de Araújo SC; Moraes EL; Oxman AD
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD007017. PubMed ID: 25966337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical policies: effects of financial incentives for prescribers.
    Sturm H; Austvoll-Dahlgren A; Aaserud M; Oxman AD; Ramsay C; Vernby A; Kösters JP
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006731. PubMed ID: 17636851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitions and incentives for smoking cessation.
    Cahill K; Perera R
    Cochrane Database Syst Rev; 2011 Apr; (4):CD004307. PubMed ID: 21491388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incentives for preventing smoking in children and adolescents.
    Johnston V; Liberato S; Thomas D
    Cochrane Database Syst Rev; 2012 Oct; 10():CD008645. PubMed ID: 23076949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 215.